Kemnay Advisory Services’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.4K Sell
116
-731
-86% -$79.5K ﹤0.01% 817
2026
Q1
$78.2K Sell
847
-577
-41% -$57.9K 0.01% 165
2025
Q4
$145K Buy
+1,424
New +$127K 0.02% 73

Other funds holding GH

Kemnay Advisory Services's GH Position: Q2 2026 in Review

Kemnay Advisory Services reduced its Guardant Health (GH) stake by 86% in Q2 2026, selling an estimated $79.5K and leaving 116 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #817.

Kemnay Advisory Services first reported a position in GH in Q4 2025 and has held it in 3 quarters since. The position peaked at $145K in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Kemnay Advisory Services held 116 shares of Guardant Health worth $17.4K as of Q2 2026.
  • Kemnay Advisory Services sold 731 Guardant Health shares in Q2 2026, an estimated $79.5K.
  • Guardant Health made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #817 holding.
  • Kemnay Advisory Services first reported a position in Guardant Health in Q4 2025 and has held it in 3 quarters since.
  • Kemnay Advisory Services's Guardant Health position peaked at $145K in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.